Another table comparing the remuneration of our Chairman and previous CEO against peers.
I mentioned this before but if Kate is taking his previous day-to-day CEO duties, would it be reflected in his remuneration.
I do, however, acknowledged his increased oversight for the enlarged group.
Column 1 Column 2 Column 3 Column 4 Column 5 0 Company Market cap ($million) Position Base salary and fees 12 month share price change 1 Alcidion group 37.9 Ray Blight (Executive Chairman) $261,613 -9% 2 Volpara Health 162.1 Dr Ralph Highnam (Executive Director) $280,305 +71% 3 Impedimed 170.5 Richard Carreon (Managing Director and CEO) $646,690 -42% 4 LBT Innovations 23.1 Brent Barnes (Managing Director and CEO) $237,000 -64% 5 Capitol Health 233.7 Andrew Demetriou (Chairman and Non-Executive Director) $254,160 +5% 6 Capitol Health 233.7 Andrew Harrison (Managing Director and CEO) $633,076 +5% 7 Medadvisor 52.9 Robert Read (CEO) $270,474 +11%
- Forums
- ASX - By Stock
- ALC
- Ann: Notice of Annual General Meeting/Proxy Form
Ann: Notice of Annual General Meeting/Proxy Form, page-14
-
- There are more pages in this discussion • 56 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ALC (ASX) to my watchlist
|
|||||
Last
7.9¢ |
Change
0.007(9.72%) |
Mkt cap ! $106.0M |
Open | High | Low | Value | Volume |
7.6¢ | 7.9¢ | 7.4¢ | $110.4K | 1.463M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 72983 | 7.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 91409 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 72983 | 0.076 |
1 | 350000 | 0.075 |
2 | 55568 | 0.072 |
3 | 152870 | 0.070 |
3 | 343055 | 0.069 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 91409 | 2 |
0.080 | 31731 | 3 |
0.081 | 22000 | 1 |
0.082 | 94883 | 1 |
0.083 | 6451 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
ALC (ASX) Chart |